Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. Also, they are used to cure several diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and others. Antibiotics are also known as antibacterial or antimicrobials. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been used to treat several bacterial infections. Increase in the incidence of chronic and infectious diseases across the globe and the efficacy of antibiotics to treat a wide spectrum of bacterial infections have led to the rapid growth of the global antibiotics market.Antibiotics Market xx was valued at US$ Xx Billion in 2024 and is projected to grow at a CAGR of xx% to reach US$ xx  Billion by 2034.

The report " Antibiotics Market, By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors), By Drug (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, and Sulfonamides, and Other), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”.

Key Highlights:

• In February 2020, Seattle Genetics and Astellas Announce Updated Result from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer.
• In January 2020, Janssen Announces European Commission Approval for Expanded Use of Erleada (apalutamide) for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Analyst View:

Rising prevalence of infectious diseases, such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are the other factors propelling the market. Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the forecast period. However, the indiscriminate and sustained use of antibiotics in the last few decades has led to the development of antibiotic-resistant bacteria and pathogens. Infections such as tuberculosis, pneumonia, and gonorrhoea, which were initially susceptible to antibiotics, have become immune to these drugs.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Antibiotics Market, By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors), By Drug (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, and Sulfonamides, and Other), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”.

Key Market Insights from the report:        

Antibiotics Market xx was valued at US$ Xx Billion in 2024 and is projected to grow at a CAGR of xx% to reach US$ xx  Billion by 2034. The market report has been segmented based on booking type, service type, vehicle type and region.

• Based on the action mechanism, Folic acid and RNA synthesis inhibitors are anticipated to witness significant CAGRs over the forecast period. Developments of several antiviral drugs, which inhibit transcription and reverse transcription process, are anticipated to support the growth. Folic acid inhibitor sulfa drugs are anticipated to grow as they have a wide scope of application.
• Based on the drug, carbapenems class is anticipated to foster the market over the forecast period due to increasing incidence of pneumonia, bloodstream infections, and Urinary Tract Infections (UTI).
• Based on the region, Asia Pacific held a significant share in the past on account of the large population base, high prevalence of infectious diseases, regulation reforms, and greater usage of generic medicines. Latin America, especially Brazil, with its strong growth in the pharmaceuticals sector is also projected to exhibit remunerative growth. The outbreak of certain viruses, such as Ebola, in Africa contributed to the growth of the region.

Competitive Landscape:

The prominent player operating in the antibiotics market includes Pfizer, Inc.; Janssen Pharmaceuticals; Abbott Laboratories; GlaxoSmithKline plc; Sanofi S.A.; Novartis AG; Bayer AG; Bristol Myers Squibb Company; Eli Lilly and Company; and Astellas Pharma, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. Also, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com